ArticleInternational journal of health policy and management2020
Defining the Benefit Package of Thailand Universal Coverage Scheme: From Pragmatism to Sophistication.
Article in International journal of health policy and management, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- A scoping review of obesity policies and reimbursement landscape: global insights and lessons for Thailand.Implementation science communications · 2026Article
- Thailand's health financing resilience during COVID-19: leveraging universal health coverage to tackle the pandemic.Health economics review · 2026Article
- Optimal insurance coverage and pricing of outpatient drugs in Iran: a cost- and chronicity-based adaptation of the vertical equity model.International journal for equity in health · 2026Article
- The appropriateness of finerenone initiation, dosing, and outcomes in diabetic kidney disease: data from real world practice.BMC nephrology · 2026Article
- Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?PharmacoEconomics - open · 2025Article
- Characterization of treatment intensified (add-on to metformin) adults with type 2 diabetes in Thailand: A cross-sectional real-world study (CONVERGE).Journal of diabetes investigation · 2025Article
- Early health technology assessment of tongue swab for non-sputum based pulmonary tuberculosis diagnosis in Thailand.The Lancet regional health. Southeast Asia · 2025Article
- Challenges in institutionalizing evidence-informed priority setting for health service packages: a qualitative document and interview analysis from Iran.Health research policy and systems · 2024Article
- Bridging Real-World Data Gaps: Connecting Dots Across 10 Asian Countries.JMIR medical informatics · 2024Article
- Understanding the extent of economic evidence usage for informing policy decisions in the context of India's national health insurance scheme: Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (PM-JAY).BMJ global health · 2024Article
- A situational and stakeholder analysis of health technology assessment in Zimbabwe.International journal of technology assessment in health care · 2024Article
- Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand.Health policy and planning · 2023Article
- Procedural fairness in health financing for universal health coverage: why, what and how.Health policy and planning · 2023Article
- From Universal Health Coverage services packages to budget appropriation: the long journey to implementation.BMJ global health · 2023Review
- Institutionalisation Is a Vital Element for Fairness of Priority Setting in the Package Design if the Target is Universal Health Coverage Comment on "Evidence-Informed Deliberative Processes for Health Benefits Package Design - Part II: A Practical Guide".International journal of health policy and management · 2023Article
- Country readiness and prerequisites for successful design and transition to implementation of essential packages of health services: experience from six countries.BMJ global health · 2023Review
- Contracting the private health sector in Thailand's Universal Health Coverage.PLOS global public health · 2023Article
- International Journal of Health Policy and Management (IJHPM): A Decade of Advancing Knowledge and Influencing Global Health Policy (2013-2023).International journal of health policy and management · 2023Article
- Enhancing Priority-Setting Decision-Making Process Through Use of Intersectionality for Public Participation.International journal of health policy and management · 2023Article
- Clinical Study of Long-Term Survival in Colorectal Cancer Patients in Thailand: A 10-Year Follow-Up.Iranian journal of public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benefit package is crucial for implementing universal health coverage (UHC). This editorial analyses how the benefit package of the Thai Universal Coverage Scheme (UC Scheme) evolved from an implicit comprehensive package which covered all conditions and interventions (with a few exceptions), to additional explicit positive lists. In 2002 when the Thai UC Scheme was launched; the comprehensive benefit package, including medicines in the national essential list of medicines, formerly offered by the previous schemes were pragmatically adopted. Later, when capacities of producing evidence on health technology assessment (HTA) increased, rigorous assessment of cost effectiveness is mandatorily required for inclusion of new interventions into the Thai UC Scheme benefit package. This contributed to evidence-informed policy decisions. To prevent emptied promises, whichever policy choices are made about the benefit package, either using a negative or a positive list, developing country governments need to make quality health services available and accessible by the entire population. Political decision on benefit package should be informed by evidence on cost effectiveness, equity dimension and health system capacity to deliver equitable services. Low- and middle-income countries need to strengthen HTA capacity to generate evidence and inform policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.